4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-004065
Chief Business Officer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Levin Michaela · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-31 | Grant or award : show line 1 in the form | +30,000 | 30,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-31 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +130,000 | 130,000 | D |
Loading xslF345X06/form4.xml…